Similarly, if transcription-dependent, TOP2B mediated DSBs trigger t-AL translocations as suggested above, then harmful genotoxic effects may be minimized by employing anti-cancer regimens in which a transcriptional inhibitor precedes administration of a TOP2 poison. The gene discussed is TOP2B; the disease is cancer.